Novavax, Inc. (NVAX) Cash Flow Statement

The significant divergence between net income and operating cash flow indicates that non-cash items and working capital swings are the primary drivers of bottom-line results. Investors should monitor this disconnect, as it implies that accounting profits are frequently decoupled from the actual liquidity available to fund ongoing R&D and operational requirements.

The inability to maintain consistent positive free cash flow suggests that the company's current business model is not yet self-sustaining. The sharp swings in FCF margins appear to be a direct consequence of the timing of collaboration payments, which masks the underlying cash burn inherent in the company's high-cost manufacturing and R&D structure.

These dramatic fluctuations in working capital suggest that the company's cash position is highly sensitive to the timing of settlement obligations and inventory management. Such volatility warrants further investigation into whether these movements represent genuine operational efficiency or merely the accounting impact of managing large, lumpy government and partner contracts.